Reports significant year-over-year revenue growth
To hold investor conference call with its first quarter 2016 financial results in early May
Surna Inc. (SRNA) (“Surna” or the “Company”), a technology company that engineers state-of-the art equipment for controlled environment agriculture (“CEA”) with special expertise in cannabis cultivation, reported its financial results for the year ended December 31, 2015.
“2015 was a transformational year for Surna as we built a stronger foundation on which to grow the business,” said Stephen Keen, Surna’s CEO. “Focused on establishing Surna as the leading supplier for cannabis cultivation equipment in the U.S., we continue to introduce ground-breaking technology such as the Surna Reflector and our hybrid building design. In 2016, we intend to expand our product commercialization efforts.”
“As part of our mission to position the Company for profitable growth, we installed a new management team in 2015. Now, we are focusing on the monetization of service components, supporting premium pricing for our existing products and commercializing our research and development efforts. In addition, we are taking measures to reduce our cost of capital to accelerate our path to profitability and, ultimately, increase shareholder value.”
Results for Fiscal Year 2015 Compared to Fiscal Year 2014
- Revenue grew 328% to $7.9 million, compared to $1.8 million, reflecting focused investments in sales and marketing, new product introductions, increased engineering services and greater demand for products as the number of state-legal cannabis markets continues to grow.
- Operating expenses were $4.1 million, compared to $3.5 million. Although operating expenses increased 16% year over year, such costs declined as percentage of revenue to 52% in 2015 from 190% in 2014.
- Advertising and marketing expenses increased to $310,000, compared to $241,000. Now that more states have legal cannabis, Surna is covering a wider geographic area with marketing events and conferences.
- Product development costs were $708,000, compared to $319,000 as Surna increases investments in its hybrid building and lighting technologies.
- SG&A expenses increased 3% to $3.0 million, compared to $2.9 million.
- Net loss was $5.3 million, or $0.04 per share, compared to $3.0 million, or $0.03 per share.
- Cash, accounts receivable, inventory and prepaid assets at December 31, 2015 were $2.1 million.
- Deferred revenue was $986,000, up from $408,000. Deferred revenue represents contracts that are in progress, as the Company does not recognize revenue until the equipment is shipped or services are performed
Investor Conference Call for the First Quarter 2016 Results
Surna management intends to host an investor conference call in combination with its first quarter 2016 financial results anticipated to take place in mid-May 2016. The Company will provide the date and access instructions for the call in the coming weeks.
Surna Inc. (http://www.surna.com) develops innovative technologies and products that monitor, control and or address the energy and resource intensive nature of indoor cannabis cultivation. Currently, the Company’s revenue stream is based on its main product offerings – supplying industrial technology and products to commercial indoor cannabis grow facilities.
Headquartered in Boulder, CO, Surna’s diverse engineering team is tasked with creating novel energy and resource efficient solutions, including the Company’s signature water-cooled climate control platform. The Company’s engineers continuously seek to create technology that solve the highly specific demands of the cannabis industry for temperature, humidity, light and process control.
Surna’s goal is to provide intelligent solutions to improve the quality, the control and the overall yield and efficiency of CEA. Though its clients do, the Company neither produces nor sells cannabis.
Forward Looking Statements
This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors including Surna’s ability to monetize service components, Surna’s support of premium prices for existing products, commercialization of research and development efforts and continued expansion of legal cannabis markets. Other risks and uncertainties include, among others, risks related to new products, services, and technologies, government regulation and taxation, and fraud. In addition, the current global economic climate amplifies many of these risks. More information about factors that potentially could affect Surna’s financial results is included in Surna’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Statement About Cannabis Markets
The use, possession, cultivation, and distribution of cannabis is prohibited by federal law. This includes medical and recreational cannabis. Although certain states have legalized medical and recreational cannabis, companies and individuals involved in the sector are still at risk of being prosecuted by federal authorities. Further, the landscape in the cannabis industry changes rapidly. What was the law last week is not the law today and what is the law today may not be the law next week. This means that at any time the city, county, or state where cannabis is permitted can change the current laws and/or the federal government can supersede those laws and take prosecutorial action. Given the uncertain legal nature of the cannabis industry, it is imperative that investors understand that the cannabis industry is a high-risk investment. A change in the current laws or enforcement policy can negatively affect the status and operation of our business, require additional fees, stricter operational guidelines and unanticipated shut-downs.
Consolidated Balance Sheets as of December 31, 2015 and 2014
December 31, 2015 2014 ASSETS Current Assets Cash $ 330,557 $ 689,963 Accounts receivable (net of allowance for doubtful accounts of $40,873 and $10,000, respectively) 299,194 394,830 Note receivable 207,218 100,000 Inventory 1,261,802 264,031 Prepaid expenses 193,969 57,089 Total Current Assets 2,292,740 1,505,913 Noncurrent Assets Property and equipment, net 162,530 163,815 Intangible assets, net 647,464 651,564 Total Noncurrent Assets 809,994 815,379 TOTAL ASSETS $ 3,102,734 $ 2,321,292 LIABILITIES AND SHAREHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued liabilities $ 2,066,803 $ 411,828 Deferred revenue 986,445 408,199 Current portion of long term debt 1,551 9,731 Amounts due to shareholders 216,995 303,672 Convertible promissory notes, net 1,227,761 - Convertible accrued interest 201,257 - Derivative liability on conversion feature 472,967 847,438 Derivative liability on warrants 139,192 304,432 Total Current Liabilities 5,312,971 2,285,300 NONCURRENT LIABILITIES Convertible promissory notes, net 523,822 488,544 Convertible accrued interest 80,674 89,311 Other accrued interest - 112,812 Promissory note due shareholders - 195,759 Vehicle loan 32,564 33,318 Total Noncurrent Liabilities 637,060 919,744 TOTAL LIABILITIES 5,950,031 3,205,044 Commitments and Contingencies - - SHAREHOLDERS' DEFICIT Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 77,220,000 shares issued and outstanding 772 772 Common stock, $0.00001 par value; 350,000,000 shares authorized; 125,839,862 and 113,511,250 shares issued and outstanding, respectively 1,259 1,135 Paid in capital 8,214,271 4,881,918 Accumulated other comprehensive income - - Accumulated deficit (11,063,599) (5,767,577) Total Shareholders' Deficit (2,847,297) (883,752) TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT $ 3,102,734 $ 2,321,292
Consolidated Statements of Operations and Comprehensive Loss
2015 2014 Revenue $ 7,865,243 $ 1,838,912 Cost of revenue 6,924,402 1,534,918 Gross margin 940,841 303,994 Operating expenses: Advertising and marketing expenses 309,620 240,784 Product development costs 707,517 319,430 Selling, general and administrative expenses 3,037,547 2,936,244 Total operating expenses 4,054,684 3,496,458 Operating loss (3,113,843) (3,192,464) Other income (expense): Interest and other income (expense), net 24,547 - Interest expense (873,207) (357,579) Amortization of debt discount on convertible promissory notes (2,220,115) (476,044) Loss on extinguishment of debt (78,155) Gain on change in derivative liabilities 964,751 1,051,889 Total other income (expense) (2,182,179) 218,266 Loss from continuing operations before provision for income taxes (5,296,022) (2,974,198) Provision for income taxes - - Loss from continuing operations (5,296,022) (2,974,198) Loss from discontinued operations - (17,771) Net loss (5,296,022) (2,991,969) Comprehensive loss - - Comprehensive loss $ (5,296,022) $ (2,991,969) Loss per common share from continuing operations - basic $ (0.04) $ (0.03) Loss per common share from discontinued operations - basic $ (0.00) $ (0.00) Loss per common share - basic $ (0.04) $ (0.03) Weighted average number of common shares outstanding, basic 119,967,118 100,687,113